Skip to main content
SpringerLink
Log in

Glomerular Ultrastructural Changes in Microalbuminuric IDDM-Patients

  • Chapter
The Kidney and Hypertension in Diabetes Mellitus

  • 110 Accesses

Abstract

Since the term »microalbuminuria« (MA) was coined in 1982 [1] elevated albumin excretion rate has been regarded as the best indicator to signal early diabetic nephropathy [2–5]. Two main aspects of renal function at this stage of diabetic nephropathy, are the relation to glomerular structure and the impact of blood glucose control. Improved blood glucose control has been shown to reduce the risk of developing overt nephropathy in patients with MA [6,7] and retard the progression of AER [8], but the concomitant ultrastructural changes were not investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Viberti GC, Mackintosh D, Bilous RW, Pickup JC, Keen H. Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia. Kidney Int 1982; 21: 714–720.

    Article  CAS  PubMed  Google Scholar 

  2. Parving H-H, Oxenbøll B, Svendsen PAA, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982; 100: 500–505.

    Google Scholar 

  3. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; i: 1430–1432.

    Article  Google Scholar 

  4. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93.

    Article  CAS  PubMed  Google Scholar 

  5. Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PA, Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984; 26: 406–410.

    Article  CAS  PubMed  Google Scholar 

  6. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T. Effect of improved metabolic control on loss of kidney function in type I (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 1991; 34: 164–170.

    Article  CAS  PubMed  Google Scholar 

  7. Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenquist U. Intensified conventional insulin treatment retards the microvascular complications of insulin dependent diabetes mellitus (IDDM): The Stockholm diabetes intervention study (SDIS) after five years. J Intern Med 1991; 230: 101–108.

    Article  CAS  PubMed  Google Scholar 

  8. Dahl-Jørgensen K, Bjøro T, Kierulf P, Sandvik L, Bangstad H-J, Hanssen KF. Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int 1992; 41: 920–923.

    Article  PubMed  Google Scholar 

  9. Hirose K, Østerby R, Nozawa M, Gundersen HJ. Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int 1982; 21: 689–695.

    Article  CAS  PubMed  Google Scholar 

  10. Østerby R. A quantitative electron microscopic study of mesangial regions in glomeruli from patients with short term juvenile diabetes mellitus. Lab Invest 1973; 29: 99–110.

    PubMed  Google Scholar 

  11. Gundersen HJG, Bendtsen TF, Korbo L, et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988; 96: 379–394.

    Article  CAS  PubMed  Google Scholar 

  12. Walker JD, Close CF, Jones SL, et al. Glomerular structure in type I (insulin-dependent) diabetic patients with normo-and microalbuminuria. Kidney Int 1992; 41: 741–748.

    Article  CAS  PubMed  Google Scholar 

  13. Bangstad H-J, Østerby R, Dahl-Jørgensen K, et al. Early glomerulopathy is present in young Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1993; 36: 523–529.

    Article  CAS  PubMed  Google Scholar 

  14. Østerby R. »Research methodologies related to renal complications: structural changes.« In Research Methodologies in Human Diabetes, Part 2, Mogensen CE, Standi E, eds. Berlin, New York: Walter de Gruyter, 1995; pp 289–309.

    Google Scholar 

  15. Østerby R. Early phases in the development of diabetic nephropathy. Acta Med Scand 1975; 574: Suppl.: 1–80.

    Google Scholar 

  16. Steffes MW, Sutherland DER, Goetz FC, Rich SS, Mauer SM. Studies of kidney and muscle biopsies in identical twins discordant for type 1 diabetes mellitus. N Engl J Med 1985; 312: 1281–1287.

    Google Scholar 

  17. Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM. Glomerular lesions and urinary albumin excretion in Type 1 diabetes without overt proteinuria. N Engl J Med 1989; 320: 966–970.

    Article  CAS  PubMed  Google Scholar 

  18. Bader R, Bader H, Grund KE, Mackensen Haen S, Christ H, Bohle A. Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters. Pathol Res Pract 1980; 167: 204–216.

    Article  CAS  PubMed  Google Scholar 

  19. Lane PH, Steffes MW, Fioretto P, Mauer SM. Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 1993; 43: 661–667.

    Article  CAS  PubMed  Google Scholar 

  20. Østerby R, Bangstad H-J, Nyberg G, Walker JD, Viberti GC. A quantitative ultrastructural study of juxtaglomerular arterioles in IDDM patients with micro-and normoalbuminuria. Diabetologia 1995; 38: 1320–1327.

    Article  PubMed  Google Scholar 

  21. Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Glomerular basement membrane thickness. Diabetologia 1979; 16: 319–324.

    Article  CAS  PubMed  Google Scholar 

  22. Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. The mesangial region. Diabetologia 1979; 17: 243–248.

    Article  CAS  PubMed  Google Scholar 

  23. Kern TS, Engerman RL. Kidney morphology in experimental hyperglycemia. Diabetes 1987; 36: 244–249.

    Article  CAS  PubMed  Google Scholar 

  24. Petersen J, Ross J, Rabkin R. Effect of insulin therapy on established diabetic nephropathy in rats. Diabetes 1988; 37: 1346–1350.

    Article  CAS  PubMed  Google Scholar 

  25. Mauer SM, Brown DM, Matas AJ, Steffes MW. Effects of pancreatic islet transplantation on the increased urinary albumin excretion rates in intact and uninephrectomized rats with diabetes mellitus. Diabetes 1978; 27: 959–964.

    Article  CAS  PubMed  Google Scholar 

  26. Steffes MW, Brown DM, Basgen JM, Mauer SM. Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats. Diabetes 1980; 29: 509–515.

    Article  CAS  PubMed  Google Scholar 

  27. Orloff MJ, Yamanaka N, Greenleaf GE, Huang Y, Huang D, Leng X. Reversal of mesangial enlargement in rats with long-standing diabetes by whole pancreas transplantation. Diabetes 1986; 35: 347–354.

    Article  CAS  PubMed  Google Scholar 

  28. Bilous RW, Mauer SM, Sutherland DER, Najarian JS, Goetz FC, Steffes MW. The effect of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med 1989; 321: 80–85.

    Article  CAS  PubMed  Google Scholar 

  29. Bangstad H-J, Osterby R, Dahl-Jørgensen K, Berg KJ, Hartmann A, Hanssen KF. Improvement of blood glucose control retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 1994; 37: 483–490.

    Article  CAS  PubMed  Google Scholar 

  30. Barbosa J, Steffes MW, Connett J, Mauer M. Hyperglycemia is causally related to diabetic renal lesions. Diabetes 1992; 41: 9A.

    Google Scholar 

  31. Wilczek H, Jaremko G, Tyden G, Groth CG. Evolution of diabetic nephropathy in kidney grafts. Transplantation 1995; 59: 51–57.

    Article  CAS  PubMed  Google Scholar 

  32. Lane PH, Steffes MW, Mauer SM. Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes 1992; 41: 581–586.

    Article  CAS  PubMed  Google Scholar 

  33. Fioretto P, Steffes MW, Mauer SM. Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 1994; 43: 1358–1364.

    Article  CAS  PubMed  Google Scholar 

  34. Mogensen CE, Hansen KW. Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes. Diabetes Care 1992; 15: 1192–1204.

    Article  CAS  PubMed  Google Scholar 

  35. Bangstad H-J, Kofoed-Enevoldsen A, Dahl-Jørgensen K, Hanssen KF. Glomerular charge selectivity and the influence of improved blood glucose control in Type 1 diabetic patients with microalbuminuria. Diabetologia 1992; 35: 1165–1170.

    Article  CAS  PubMed  Google Scholar 

  36. Silbiger S, Crowley S, Shan Z, Brownlee M, Satriano J, Schlondorff D. Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge. Kidney Int 1993; 43: 853–864.

    Article  CAS  PubMed  Google Scholar 

  37. Brownlee M, Spiro RG. Glomerular basement membrane metabolism in the diabetic rat: in vivo studies. Diabetes 1979; 28: 121–125.

    Article  CAS  PubMed  Google Scholar 

  38. Cagliero E, Roth T, Roy S, Lorenzi M. Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes 1991; 40: 102–110.

    Article  CAS  PubMed  Google Scholar 

  39. Roy S, Sala R, Cagliero E, Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 1990; 87: 404–408.

    Article  CAS  PubMed  Google Scholar 

  40. Ledbetter S, Copeland EJ, Noonan D, Vogeli G, Hassel JR. Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 1990; 39: 196–203.

    Article  CAS  PubMed  Google Scholar 

  41. Poulsom R, Kurkinen M, Prockop DJ, Boot-Handford RP. Increased steady-state levels of laminin B1 mRNA in kidneys of long term streptozotocin-diabetic rats. J Biol Chem 1988; 263: 10072–10076.

    CAS  PubMed  Google Scholar 

  42. Ayo SH, Radnik RA, Garoni JA, Glass II WF, Kreisberg JI. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 1990; 136: 1339–1348.

    CAS  PubMed  Google Scholar 

  43. Shimomura H, Spiro RG. Studies on the macromolecular components of human glomerular basement membrane and alterations in diabetes: decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 1987; 36: 374–381.

    Article  CAS  PubMed  Google Scholar 

  44. Olgemøller B, Schwabbe S, Gerbitz KD, Schleicher ED. Elevated glucose decreases the content of a basement associated heparan sulphate proteoglycan in proliferating cultured porcine mesangial cells. Diabetologia 1992; 35: 183–186.

    Article  PubMed  Google Scholar 

  45. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984; 101: 527–537.

    Article  CAS  PubMed  Google Scholar 

  46. Berg TJ, Torjesen PA, bangstad H-J, Bucala R, Østerby R, Hanssen KF. Advanced glycosylation endproducts are related to changes in kidney morphology in type 1 diabetic patients (Abstract). Diabetologia 1995; 38: 179A.

    Google Scholar 

  47. Østerby R, Nyberg G. New vessel formation in the renal corpuscles in advanced diabetic glomerulopathy. J Diabetic Compl 1987; 1: 122–127.

    Article  Google Scholar 

  48. Østerby R. Renal pathology in diabetes mellitus. Curr Opin Nephrol Hypertens 1993; 2: 475–483.

    Article  PubMed  Google Scholar 

  49. Kashgarian M, Sterzel RB. The pathobiology of the mesangium. Kidney Int 1992; 41: 524–529.

    Article  CAS  PubMed  Google Scholar 

  50. Hawkins NJ, Wakefield D, Charlesworth JA. The role of mesangial cells in glomerular pathology. Pathology 1990; 22: 24–32.

    Article  CAS  PubMed  Google Scholar 

  51. Rudberg S, Østerby R, Dahlquist G, Nyberg G, Persson B. Predictors of renal morphological changes in the transitional stage of microalbuminuria in IDDM adolescents. (Abstract). Diabetologia 1996; 39:Suppl. 1: A301.

    Google Scholar 

  52. Østerby R. Lessons from kidney biopsies. Diabetes/Metabolism Reviews 1996; 12: in press.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Aker Sykehus, Oslo, Norway and Laboratory for Electron Microscopy, Aarhus Kommunehospital, Aarhus, Denmark

    Hans-Jacob Bangstad & Ruth Østerby

Authors
  1. Hans-Jacob Bangstad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ruth Østerby
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Department M (Diabetes & Endocrinology), Aarhus Kommunehospital University Hospitals in Aarhus, Aarhus C, Denmark

    Carl Erik Mogensen

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bangstad, HJ., Østerby, R. (1996). Glomerular Ultrastructural Changes in Microalbuminuric IDDM-Patients. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6749-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6749-0_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6751-3

  • Online ISBN: 978-1-4757-6749-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation